PMID- 17594074 OWN - NLM STAT- MEDLINE DCOM- 20080226 LR - 20220408 IS - 0342-4642 (Print) IS - 0342-4642 (Linking) VI - 33 IP - 9 DP - 2007 Sep TI - Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. PG - 1563-70 AB - OBJECTIVE: Little information is available regarding current practice in continuous renal replacement therapy (CRRT) for the treatment of acute renal failure (ARF) and the possible clinical effect of practice variation. DESIGN: Prospective observational study. SETTING: A total of 54 intensive care units (ICUs) in 23 countries. PATIENTS AND PARTICIPANTS: A cohort of 1006 ICU patients treated with CRRT for ARF. INTERVENTIONS: Collection of demographic, clinical and outcome data. MEASUREMENTS AND RESULTS: All patients except one were treated with venovenous circuits, most commonly as venovenous hemofiltration (52.8%). Approximately one-third received CRRT without anticoagulation (33.1%). Among patients who received anticoagulation, unfractionated heparin (UFH) was the most common choice (42.9%), followed by sodium citrate (9.9%), nafamostat mesilate (6.1%), and low-molecular-weight heparin (LMWH; 4.4%). Hypotension related to CRRT occurred in 19% of patients and arrhythmias in 4.3%. Bleeding complications occurred in 3.3% of patients. Treatment with LMWH was associated with a higher incidence of bleeding complications (11.4%) compared to UFH (2.3%, p = 0.0083) and citrate (2.0%, p = 0.029). The median dose of CRRT was 20.4 ml/kg/h. Only 11.7% of patients received a dose of > 35 ml/kg/h. Most (85.5%) survivors recovered to dialysis independence at hospital discharge. Hospital mortality was 63.8%. Multivariable analysis showed that no CRRT-related variables (mode, filter material, drug for anticoagulation, and prescribed dose) predicted hospital mortality. CONCLUSIONS: This study supports the notion that, worldwide, CRRT practice is quite variable and not aligned with best evidence. FAU - Uchino, Shigehiko AU - Uchino S AD - Jikei University School of Medicine, Intensive Care Unit, Department of Anesthesiology, Tokyo, Japan. FAU - Bellomo, Rinaldo AU - Bellomo R FAU - Morimatsu, Hiroshi AU - Morimatsu H FAU - Morgera, Stanislao AU - Morgera S FAU - Schetz, Miet AU - Schetz M FAU - Tan, Ian AU - Tan I FAU - Bouman, Catherine AU - Bouman C FAU - Macedo, Ettiene AU - Macedo E FAU - Gibney, Noel AU - Gibney N FAU - Tolwani, Ashita AU - Tolwani A FAU - Oudemans-van Straaten, Heleen AU - Oudemans-van Straaten H FAU - Ronco, Claudio AU - Ronco C FAU - Kellum, John A AU - Kellum JA LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20070627 PL - United States TA - Intensive Care Med JT - Intensive care medicine JID - 7704851 RN - 0 (Anticoagulants) RN - 0 (Benzamidines) RN - 0 (Citrates) RN - 0 (Guanidines) RN - 1Q73Q2JULR (Sodium Citrate) RN - 9005-49-6 (Heparin) RN - Y25LQ0H97D (nafamostat) SB - IM CIN - Intensive Care Med. 2007 Sep;33(9):1503-5. PMID: 17594073 MH - Acute Kidney Injury/epidemiology/*therapy MH - Aged MH - Anticoagulants/therapeutic use MH - Arrhythmias, Cardiac/epidemiology MH - Benzamidines MH - Citrates/therapeutic use MH - Drug Utilization/*statistics & numerical data MH - Female MH - Guanidines/therapeutic use MH - Hemorrhage/epidemiology MH - Heparin/therapeutic use MH - Hospital Mortality MH - Humans MH - Hypotension/epidemiology MH - Intensive Care Units MH - Male MH - Middle Aged MH - Practice Patterns, Physicians'/*statistics & numerical data MH - Prospective Studies MH - Recovery of Function MH - Renal Replacement Therapy/adverse effects/methods/*statistics & numerical data MH - Sodium Citrate EDAT- 2007/06/28 09:00 MHDA- 2008/02/27 09:00 CRDT- 2007/06/28 09:00 PHST- 2006/11/23 00:00 [received] PHST- 2007/05/29 00:00 [accepted] PHST- 2007/06/28 09:00 [pubmed] PHST- 2008/02/27 09:00 [medline] PHST- 2007/06/28 09:00 [entrez] AID - 10.1007/s00134-007-0754-4 [doi] PST - ppublish SO - Intensive Care Med. 2007 Sep;33(9):1563-70. doi: 10.1007/s00134-007-0754-4. Epub 2007 Jun 27.